Establishes "Cindi's Law" requiring p53 tests for uterine cancer diagnosis.
Cindi's Law" mandates that all abnormal endometrial samples include a p53 test for uterine cancer diagnosis and treatment. This law adds a new section to Chapter 191 of RSMo, requiring the p53 test in addition to other tests. The p53 test detects abnormalities in the p53 protein, indicating cancer invasiveness, severity, and prognosis.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.